The findings of a small French study may be reassuring to those with histories of the heart condition who are reluctant to get vaccinated, experts said.
A health care worker administers a dose of the Pfizer-BioNTech Covid-19 vaccine at a pop-up vaccination site at Hammons Field in Springfield, Mo., on Aug. 3.The Pfizer-BioNTech Covid-19 vaccine appears to be safe in people previously diagnosed with myocarditis, according to a small study presented Thursday at a European medical conference.
Researchers from France studied 55 patients, most of them young men, who had been hospitalized with myocarditis within the last five years and were later inoculated with a Covid-19 vaccine. The results may be reassuring to those with a history of myocarditis who are reluctant to get vaccinated. In February, the Centers for Disease Control and Prevention recommended people over the age of 12 and young men
She noted that the risk of severe complications from Covid is much greater than the risk of vaccine-induced myocarditis., which highlights this is something that is not benign in some children," Poehling said.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Covid: Parts of Lincolnshire see Covid infections double in a weekHealth chiefs in Lincolnshire say the figure could be much higher due to fewer people testing.
Weiterlesen »
Covid-19: Five Covid-related deaths and 506 in hospitalThe total number of deaths linked to the virus reported by Stormont's Department of Health is 3,258.
Weiterlesen »
Pfizer and BioNTech plan to seek authorization for second COVID booster for people 65 and upNEW: Pfizer and its partner BioNTech plan to seek emergency authorization for a second COVID booster shot for people 65 and older, Axios has confirmed.
Weiterlesen »
AP source: Pfizer seeking OK for 4th COVID dose for seniorsWASHINGTON (AP) — Drugmaker Pfizer is expected to request authorization this week for an additional COVID-19 booster dose for seniors, according to a person familiar with the matter. It would add a fourth dose to the regimen, which currently consists of a primary series of two shots, followed months later by a booster dose, in an effort to provide maximum protection to the over-65 population that has been hit hardest by the pandemic.
Weiterlesen »
AP source: Pfizer seeking OK for 4th COVID dose for seniorsWASHINGTON (AP) — Drugmaker Pfizer is expected to request authorization this week for an additional COVID-19 booster dose for seniors, according to a person familiar with the matter.
Weiterlesen »
Pfizer to reportedly seek authorization for 2nd COVID-19 booster for older adultsPfizer will seek emergency use authorization to provide a second COVID-19 booster shot for adults 65 years and older, multiple media outlets are reporting.
Weiterlesen »